tesamorelin/ ipamorelin Tesamorelin + (10mg/3mg) Tesamorelin + Ipamorelin - Simon's
Description
10.1016/s0304-3940(01)01855-9 282 ZhuG.WangX.ChenY.YangS.ChengH.WangN.et al (2010)
Sermorelin was originally approved by the FDA in 1997 for treating growth hormone deficiency in children, but was discontinued in 2008 due to manufacturing issues, not safety concerns
Co to jest
A partially purified leaf enzyme with DHAR activity was subsequently reported, but was considered likely to be cytosolic (Foyer and Halliwell 1977)
Are GHRPs on the WADA list
